Evidence map›Paper›PMID 24312140›Full record

ArticleJournal of Cancer2013

Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action.

Allal Ouhtit, Rajiv Lochan Gaur, Mohamed Abdraboh, Shubha K Ireland, Prakash N Rao, Shailaja G Raj, Hamad Al-Riyami, Somya Shanmuganathan, Ishita Gupta, Subramanyam N Murthy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Chemopreventive and therapeutic effects ofFrontiers in pharmacology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Chemical diversity of dietary phytochemicals and their mode of chemoprevention.Biotechnology reports (Amsterdam, Netherlands) · 2021
    Review
  13. Article
  14. Article
  15. Mangiferin Rich Products fromMolecules (Basel, Switzerland) · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Allal Ouhtit1. Stanley S Scott Cancer Center, Louisiana Health Sciences Center, New Orleans, Louisiana. ; 2. Present address: Department of Genetics, College of Medicine and Health Sciences, Sultan Qaboos University, Oman;
Rajiv Lochan Gaur
Mohamed Abdraboh
Shubha K Ireland
Prakash N Rao
Shailaja G Raj
Hamad Al-Riyami
Somya Shanmuganathan
Ishita Gupta
Subramanyam N Murthy
Andrew Hollenbach
Madhwa Hg Raj
Sultan Qaboos University · OMAgence des Aires Marines Protégées · FRGift of Hope Organ and Tissue Donor Network · USLouisiana State University Health Sciences Center New Orleans · USMansoura University · EGSouthern University and Agricultural and Mechanical College · USXavier University of Louisiana · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional chemotherapy and radiotherapy for cancer treatment face serious challenges such as drug resistance and toxic side effects. Complementary / Alternative medicine is increasingly being practiced worldwide due to its safety beneficial therapeutic effects. We hypothesized that a super combination (SC) of known phytochemicals used at bioavailable levels could induce 100% killing of breast cancer (BC) cells without toxic effects on normal cells and that microarray analysis would identify potential genes for targeted therapy of BC. Mesenchymal Stems cells (MSC, control) and two BC cell lines were treated with six well established pro-apoptotic phytochemicals individually and in combination (super cocktail), at bioavailable levels. The compounds were ineffective individually. In combination, they significantly suppressed BC cell proliferation (>80%), inhibited migration and invasion, caused cell cycle arrest and induced apoptosis resulting in 100% cell death. However, there were no deleterious effects on MSC cells used as control. Furthermore, the SC down-regulated the expression of PCNA, Rb, CDK4, BcL-2, SVV, and CD44 (metastasis inducing stem cell factor) in the BC cell lines. Microarray analysis revealed several differentially expressed key genes (PCNA, Rb, CDK4, Bcl-2, SVV, P53 and CD44) underpinning SC-promoted BC cell death and motility. Four unique genes were highly up-regulated (ARC, GADD45B, MYLIP and CDKN1C). This investigation indicates the potential for development of a highly effective phytochemical combination for breast cancer chemoprevention / chemotherapy. The novel over-expressed genes hold the potential for development as markers to follow efficacy of therapy.

Indexed as

Breast cancerchemopreventionmetastasismicroarrayphytochemicals

Identifiers

PMID24312140
PMCPMC3842439
OpenAlexW2107191422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.